Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Eden Research ( (GB:EDEN) ) has issued an update.
Eden Research has launched a UK-only retail share offer of up to £500,000 via the BookBuild platform at 4.0 pence per new ordinary share, representing a small premium to its recent closing price and open exclusively to existing retail shareholders through participating intermediaries. The retail offer, which runs from 2–5 February 2026 and is separate from but complementary to a wider £10.7 million fundraising comprising firm and conditional placings and subscriptions, is intended to give long-standing retail investors a chance to participate while providing additional capital to accelerate the development, registration and commercial scale-up of Eden’s insecticide products and new fungicides targeting Late Blight in potatoes and Septoria in wheat, potentially strengthening its pipeline and competitive position in the crop protection market.
The most recent analyst rating on (GB:EDEN) stock is a Hold with a £4.00 price target. To see the full list of analyst forecasts on Eden Research stock, see the GB:EDEN Stock Forecast page.
Spark’s Take on GB:EDEN Stock
According to Spark, TipRanks’ AI Analyst, GB:EDEN is a Neutral.
The score is held back primarily by weak financial performance—ongoing losses and persistently negative operating/free cash flow—despite revenue growth and a relatively stable balance sheet. Technicals are supportive due to strong price momentum above key moving averages, but extremely overbought readings raise pullback risk. Valuation is neutral-to-cautious because the negative P/E reflects lack of profitability and there is no dividend yield data.
To see Spark’s full report on GB:EDEN stock, click here.
More about Eden Research
Eeden Research plc is a UK-based agricultural technology company focused on developing, registering and commercialising crop protection products, including biopesticide-based insecticide formulations and fungicides. Its current R&D and commercial strategy targets major crop diseases such as Late Blight in potatoes and Septoria in wheat, positioning the business within the sustainable crop protection and agrochemicals market.
Average Trading Volume: 553,155
Technical Sentiment Signal: Buy
Current Market Cap: £20.8M
Find detailed analytics on EDEN stock on TipRanks’ Stock Analysis page.